Abstract
Purpose: To describe a case of sympathetic ophthalmia following vitrectomy for endophthalmitis after an intravitreal injection of bevacizumab. Design: Retrospective case report. Methods: An 84-year-old male developed sympathetic ophthalmia 4 months after vitrectomy for endophthalmitis following an intravitreal injection. The inciting blind eye was enucleated. Results: Histopathology demonstrated sympathetic ophthalmia and phacoanaphylactic endophthalmitis. Visual acuity improved from 20/200 to 20/30 in the sympathizing eye with a combination of oral prednisone and azathioprine. Conclusions: Sympathetic ophthalmia can develop following exogenous endophthalmitis but has a good visual prognosis with appropriate treatment.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 236-238 |
| Number of pages | 3 |
| Journal | Ocular Immunology and Inflammation |
| Volume | 16 |
| Issue number | 5-6 |
| DOIs | |
| State | Published - Sep 2008 |
Keywords
- Endophthalmitis
- Intravitreal bevacizumab
- Phacoanaphylactic endophthalmitis
- Sympathetic ophthalmia
- Vitrectomy
ASJC Scopus subject areas
- Ophthalmology
- Immunology and Allergy